Overview of the global percutaneous coronary intervention (PCI) devices market
The traditional surgery methods include various complications such as blood loss and infections. It is also painful and takes longer to heal. This resulted in an increased demand for minimally invasive surgery (MIS) techniques such as percutaneous transluminal coronary angioplasty (PTCA), percutaneous transluminal angioplasty (PTA), and stenting procedures. These non-surgical techniques enhance the quality of life of the patients because they are less invasive. Technavio’s market research report identifies that the rapid shift toward MIS and increase in the volume of PCI procedures will be one of the primary growth drivers for the global percutaneous coronary intervention (PCI) devices market till 2021. MIS reduces the risk of complications, cost of hospitalization, and rate of hospital-acquired infections (HAI). The adoption of MI procedures is driving the demand for MI devices such as percutaneous coronary intervention devices. Technavio’s market research analysts predict that this market will grow at a CAGR of close to 6% by 2021.
The Americas is witnessing an increasing adoption of advanced interventional devices and high incidence of coronary artery disease (CAD). The global PCI devices market will continue to grow in the region during the estimated period due to the easy availability of reimbursements for the new advanced products and favorable government initiatives. For instance, the Claret Medical along with CMS provides reimbursement for Sentinel product through an ICD code.
Competitive landscape and key vendors
The vendors in the percutaneous coronary intervention (PCI) devices market are using advanced materials and modern product designs with the rising technological advancements. Key vendors are trying to remain competitive in this market by introducing new technologies and products and investing heavily in research and developmental activities.
Key vendors in this market are -
- Boston Scientific
- Abbott
- Medtronic
- Cordis
- Terumo Medical
Other prominent vendors in the market include AMG International, ASAHI INTECC, B. Braun Melsungen, BioSensors, BIOTRONIK, BrosMed Medical, Claret Medical, Comed BV, Contego Medical, Elixir Medical, EPflex Feinwerktechnik, GaltNeedleTech, Lepu Medical, Meril Life Sciences, Merit Medical Systems, optimed Medizinische Instrumente, ORBUSNEICH, Penumbra, RONTIS, SP Medical, STENTYS, and Teleflex.
Segmentation by product and analysis of the percutaneous coronary intervention (PCI) devices market
- Coronary stents
- PTCA catheters
- Coronary guidewires
- Embolic protection devices
The most common coronary heart disease witnessed in the US is CAD. Surgeons extensively use a coronary stent to treat CAD. The adoption of coronary stents will continue to grow due to the increasing technological advancements. The rapid shift towards MI surgery procedures is driving the demand for drug-eluting stents, bioabsorbable stents, and bifurcated stents. This in turn, will stimulate growth in the percutaneous coronary intervention (PCI) devices market in the coronary stent market.
Segmentation by end-user and analysis of the percutaneous coronary intervention (PCI) devices market
The influx of patients is increasing in hospitals such as multi-specialty hospitals due to the availability of favorable reimbursements. This encourages the patients to undergo heart-related surgeries in the hospitals. The presence of advanced technologies supporting MI techniques and cutting-edge robotic devices for performing PCI heart techniques will further drive the percutaneous coronary intervention (PCI) devices market’s growth in the hospitals segment.
Key questions answered in the report include
- What will the market size and the growth rate be in 2021?
- What are the key factors driving the global percutaneous coronary intervention (PCI) devices market?
- What are the key market trends impacting the growth of the global percutaneous coronary intervention (PCI) devices market?
- What are the challenges to market growth?
- Who are the key vendors in the global percutaneous coronary intervention (PCI) devices market?
- What are the market opportunities and threats faced by the vendors in the global percutaneous coronary intervention (PCI) devices market?
- What are the trending factors influencing the market shares of the Americas, APAC, and EMEA?
- What are the key outcomes of the five forces analysis of the global percutaneous coronary intervention (PCI) devices market?
Technavio also offers customization on reports based on specific client requirement.
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: INTRODUCTION
PART 05: MARKET LANDSCAPE
- Market overview
- Five forces analysis
PART 06: MARKET SEGMENTATION BY PRODUCT
- Coronary stents
- PTCA catheters
- Coronary guidewires
- Embolic Protection Devices (EPDs)
PART 07: MARKET SEGMENTATION BY END-USER
PART 08: REGIONAL LANDSCAPE
- Regional comparison
- Americas – market size & forecast
- EMEA – market size & forecast
- APAC – market size & forecast
- Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
PART 11: MARKET TRENDS
- Technological advances
- Vendors' changing focus toward bioresorbable stents
- Use of robotic PCI systems
PART 12: VENDOR LANDSCAPE
- Competitive scenario
- Key news
- M&A
PART 13: KEY VENDOR ANALYSIS
- Boston Scientific
- Abbott
- Medtronic
- Cordis
- Terumo Medical
- Other prominent vendors
PART 14: APPENDIX